Daniel Stauder
Stock Analyst at Citizens JMP
(4.23)
# 1,471
Out of 5,044 analysts
44
Total ratings
52.5%
Success rate
21.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STXS Stereotaxis | Reiterated: Buy | $4 → $3 | $1.11 | +170.27% | 2 | Aug 27, 2026 | |
| AORT Artivion | Reiterated: Buy | $53 → $48 | $21.26 | +125.78% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Reiterated: Buy | $118 → $127 | $80.69 | +57.39% | 11 | May 6, 2026 | |
| ATRC AtriCure | Reiterated: Buy | $60 → $52 | $55.81 | -6.83% | 15 | Feb 18, 2026 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $2.13 | n/a | 6 | Mar 5, 2025 |
Stereotaxis
Aug 27, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.11
Upside: +170.27%
Artivion
May 8, 2026
Reiterated: Buy
Price Target: $53 → $48
Current: $21.26
Upside: +125.78%
LeMaitre Vascular
May 6, 2026
Reiterated: Buy
Price Target: $118 → $127
Current: $80.69
Upside: +57.39%
AtriCure
Feb 18, 2026
Reiterated: Buy
Price Target: $60 → $52
Current: $55.81
Upside: -6.83%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $2.13
Upside: n/a